加捷生醫

0.00 (0.00%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

11.0095成交張數366.67本益比0.80股價淨值比1.82%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	19	16	11.9%	3.87	13.69	0.2%	0.2%	-0.1	-0.1
2026Q1	19	17	11.5%	4.08	14.07	3.3%	2.9%	0.1	0.1
2025Q4	19	17	9.3%	3.36	14.18	3.3%	3.0%	0.1	-0.2
2025Q3	18	17	8.7%	3.93	13.91	0.2%	0.2%	0.0	-0.3
2025Q2	18	16	9.1%	3.91	13.77	-0.3%	-0.2%	-0.0	-0.3
2025Q1	19	16	10.7%	3.67	13.85	15.1%	13.0%	0.1	0.1
2024Q4	15	13	8.3%	2.98	13.48	17.8%	14.6%	0.2	0.0
2024Q3	15	14	7.6%	3.22	13.75	34.8%	31.4%	-0.2	-0.2
2024Q2	16	14	12.3%	2.24	13.77	36.4%	31.8%	0.3	0.3
2024Q1	14	11	14.5%	1.89	11.64	17.7%	15.2%	0.2	0.2
2023Q4	14	10	24.3%	1.30	11.77	14.8%	11.9%	-0.1	-0.1
2023Q3	10	9	7.6%	4.37	10.05	-2.3%	-2.1%	0.3	0.3
2023Q2	10	9	7.8%	4.03	9.91	-4.2%	-3.8%	-0.0	-0.1
2023Q1	10	9	7.9%	4.09	10.00	-2.9%	-2.6%	-0.2	-0.2
2022Q4	10	9	8.0%	4.31	10.10	-0.6%	-0.5%	0.0	0.0
2022Q3	10	9	7.8%	4.32	10.08	0.8%	0.7%	0.0	-0.0
2022Q2	10	9	8.3%	3.85	10.15	0.6%	0.5%	-0.0	-0.1
2022Q1	10	9	8.7%	3.89	10.31	0.7%	0.6%	-0.1	-0.1
2021Q4	10	9	8.5%	4.15	10.21	0.6%	0.5%	0.1	0.1
2021Q3	10	9	6.4%	5.57	10.07	-1.7%	-1.5%	0.0	0.0
2021Q2	10	9	6.6%	5.87	10.12	-1.1%	-0.9%	0.0	0.0
2021Q1	10	9	6.4%	5.95	10.12	-4.1%	-3.6%	-0.1	-0.1
2020Q4	10	9	8.2%	4.79	10.22	-4.0%	-3.5%	0.2	0.2
2020Q3	7	6	13.3%	1.37	9.41	-5.3%	-4.4%	-0.0	-0.0
2020Q2	8	7	16.4%	1.28	9.54	-6.2%	-5.0%	0.1	0.1
2020Q1	8	7	15.7%	1.50	10.10	-2.4%	-1.9%	-0.0	-0.0
2019Q4	9	7	18.8%	1.34	10.09	-3.5%	-2.5%	0.3	0.3
2019Q3	9	7	20.6%	1.37	10.28	4.4%	2.8%	0.0	0.0
2019Q2	9	7	21.6%	1.34	10.37	4.6%	2.8%	0.1	0.1
2019Q1	10	7	27.6%	1.84	10.14	0.4%	0.2%	-0.2	-0.2
2018Q4	11	7	36.1%	1.09	8.71	0.4%	0.2%	0.3	0.3
2018Q3	13	7	47.9%	1.01	8.17	-31.3%	-17.5%	-0.1	-0.1
2018Q2	13	7	48.8%	0.67	8.09	-33.4%	-18.2%	-0.0	-0.0
2018Q1	13	7	48.4%	0.66	8.37	-30.5%	-16.6%	-0.2	-0.2
2017Q4	13	7	47.0%	0.66	8.43	-28.6%	-15.6%	0.3	0.3
2017Q3	15	9	38.9%	0.77	10.97	-2.1%	-1.3%	-0.2	-0.2
2017Q2	16	9	40.7%	0.75	11.61	-0.7%	-0.4%	-0.3	-0.3
2017Q1	16	9	41.1%	0.74	11.76	0.5%	0.3%	0.2	0.2
2016Q4	16	9	41.6%	1.23	11.87	–	–	-0.1	-0.2
2016Q3	16	9	40.2%	1.28	11.81	–	–	-0.2	-0.4